Lung disease study in children: new ways to understand infections
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study explores how the immune system and lung microbes affect children with lung disease. It uses extra fluid collected during a standard lung exam to look for new treatment targets.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a child from newborn to 17 years old.
- You have or are being checked for a lung disease.
- You are scheduled for a bronchoscopy (a camera test of the lungs).
- Doctors can take a small extra sample (about 2 ml) of fluid from your lungs during the test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how immune cells in the lungs relate to the microbiome (the helpful microbes in the gut) in healthy adults. It may help scientists understand what affects lung health and immune balance.
This study looks at severe lung disease in children. It may help doctors better understand and treat these conditions.
This study uses a fluid sample taken from your lungs (called bronchoalveolar lavage) to understand the specific types of inflammation in different forms of interstitial lung disease. This may help doctors tailor better treatments for you in the future.
This study looks at how children's bodies fight lung infections and how the germs themselves behave. It could help doctors better understand why some children get very sick and how to treat them in the future.
This research study examines proteins in fluid collected from your lungs during a breathing tube procedure (bronchoscopy) to better understand pneumonia. By studying these proteins, researchers hope to improve how doctors diagnose and treat lung infections.
This study looks at two substances in saliva and lung fluid—called IL-6 and TNF-α—in children with severe lung failure (ARDS) who are on a breathing machine. Measuring these markers may help doctors better understand the condition and guide treatment.
Hear when a new Lung Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.